Prognosis Tolerance Targeted therapy Overall survival Fucose Animals Cancer Microbiota COVID-19 Cationic lipids Cystic fibrosis FUT2 Mycolactone Public health Immunotherapy Wood Circulating tumor DNA Gene editing Autoimmunity Alzheimer's disease Bacteria Lebanon Biofilms Transplantation Antimicrobial peptides Cutibacterium Propionibacterium acnes Clinical trial Diagnosis Cytotoxicity Cutaneous squamous cell carcinoma Adoptive cell transfer Skin Norovirus Antimicrobial resistance Effectiveness Immunothérapie Early detection of cancer SARS-CoV-2 Abscess Evolution T cells Acinetobacter pittii Carbapenem resistance Screening Bone and joint infection Antimicrobial therapy Buruli ulcer France Merkel cell carcinoma Erwinia amylovora Acinetobacter baumannii Staphylococcus aureus Prevention Infection Case report Biomarkers Faecalibacterium prausnitzii Immunology Anti-CTLA-4 Glycans Antibodies Metastatic melanoma Granuloma Anti-PD-1 Nivolumab Breast cancer screening Brain injury Anxiety Rotavirus Primary care Costimulation blockade Melanoma Amaranthin-like lectin Infective endocarditis Pembrolizumab ABO blood group Analgesia Genetic susceptibility Antibiotic resistance Arabidopsis thaliana Histo-blood group antigens Quality of life PD-1 Inflammation Elderly BRAF inhibitor Truncal acne Biofilm Epidemiology Colonization Acne Colorectal cancer Mycobacterium ulcerans Fucosylation Cutibacterium acnes Immune checkpoint inhibitors General practitioners Adverse events Anti-PD1 Dendritic cells